Search all medical codes

PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis

CPT4 code

Name of the Procedure:

PMS2 (Postmeiotic Segregation Increased 2 [S. cerevisiae]) Gene Analysis; Full Sequence Analysis

Summary

This procedure involves the complete analysis of the PMS2 gene's DNA sequence. The PMS2 gene is significant because its mutations are associated with hereditary non-polyposis colorectal cancer (HNPCC), commonly known as Lynch syndrome. The analysis helps in identifying mutations that could lead to an increased risk of certain cancers.

Purpose

  • Medical Condition: Hereditary non-polyposis colorectal cancer (Lynch syndrome)
  • Goals: To identify mutations in the PMS2 gene which can indicate an elevated risk for colorectal and other cancers, allowing for informed decisions regarding patient management and preventive measures.

Indications

  • Family history of Lynch syndrome or related cancers
  • Early onset colorectal cancer or other Lynch syndrome–associated cancers
  • Known family mutation in the PMS2 gene
  • Unusual multiple primary cancers

Preparation

  • No special preparation is typically required.
  • A blood sample is usually needed for the test.
  • Genetic counseling is recommended before and after the procedure to discuss potential outcomes and implications.

Procedure Description

  1. Blood Sample Collection: A blood sample is taken from the patient.
  2. DNA Extraction: The DNA is extracted from the blood cells.
  3. Gene Sequencing: The full sequence of the PMS2 gene is analyzed using advanced sequencing technology to detect any mutations.
  4. Data Analysis: The results are interpreted by a genetic specialist to identify any pathogenic variants linked to Lynch syndrome.
  • Tools and Equipment: Blood collection kits, DNA extraction kits, sequencing machines, and computer software for data interpretation.
  • Anesthesia/Sedation: Not applicable as it is a non-invasive procedure.

Duration

The entire procedure, including sample collection and sequencing, can take several weeks, usually around 2-4 weeks.

Setting

The blood collection is typically done in a doctor's office, clinic, or hospital. The gene sequencing and analysis occur in specialized laboratories.

Personnel

  • Phlebotomist or nurse for blood collection
  • Laboratory technicians for DNA extraction and sequencing
  • Geneticists and genetic counselors for results interpretation and patient counseling

Risks and Complications

  • Minimal risks associated with blood sample collection such as slight bruising or infection at the puncture site.
  • Psychological impacts related to the stress of potential results.

Benefits

  • Comprehensive understanding of genetic predisposition to Lynch syndrome
  • Early detection and proactive management of colorectal and other associated cancers
  • Informative for family planning and preventative strategies for at-risk relatives

Recovery

  • Immediate resumption of normal activities post-blood collection
  • Follow-up genetic counseling to discuss results and implications

Alternatives

  • Targeted Mutation Analysis: Checks for specific known family mutations, which can be faster but less comprehensive.
  • Panel Testing: Analysis of multiple genes associated with Lynch syndrome and other hereditary cancers, providing broader genetic information.
  • Pros and cons vary based on the individual's family history and the level of detail required.

Patient Experience

  • The blood draw is usually quick and only slightly uncomfortable.
  • Patients might experience anxiety while awaiting results. Genetic counseling can help manage this.
  • No significant pain or discomfort post-procedure.

Similar Codes